EGFR and breast cancer: A novel finding in the present study is that the partial and mesenchymal EMT phenotypes displayed a high fraction of EGFR and PDGFC positivity compared with the epithelial and negative phenotypes, further supporting that these phenotypes define an aggressive type of breast cancer.